TomoTherapy to Showcase New Remote Planning Solution at ESTRO
May 03 2011 - 8:00AM
Marketwired
TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced
radiation therapy solutions for the treatment of cancer and other
diseases, today announced a new feature for its TomoTherapy®
radiation therapy treatment system that provides dosimetrists,
physicists and physicians the ability to develop and approve
treatment plans from virtually anywhere in the world. The new
Remote Planning solution extends the full TomoTherapy Planning
Station functionality to any Web-connected computer, giving cancer
centers a competitive advantage for attracting and retaining
specialists and greater flexibility to balance staff across
multiple locations.
TomoTherapy will demonstrate the Remote Planning solution at
Booth 10 in the exhibit hall at the ESTRO Anniversary Congress in
London, May 8-12, 2011. Remote Planning gives users full
TomoTherapy treatment planning capabilities from virtually any
remote location, without impacting the ability of others to
continue using the TomoTherapy Planning Stations installed within
the cancer center's TomoTherapy Network System. The feature can be
accessed from remote locations via encrypted SSL connection,
enterprise Citrix connection, VPN or other secure network access
connection, which helps ensure security and compliance with HIPAA
regulations.
Also on display at TomoTherapy's booth is the TomoHD™ treatment
system, incorporating both TomoHelical™ and TomoDirect™ treatment
modalities for broader clinical flexibility, and an interactive
demonstration of the TomoTherapy platform's patented binary
multi-leaf collimator, designed from the ground up for
intensity-modulated radiation therapy (IMRT).
TomoTherapy Events at ESTRO In addition to
the exhibit, TomoTherapy will be hosting two events in conjunction
with ESTRO. First will be a Pre-ESTRO Planning Workshop for
customers, from 1 p.m. to 5 p.m. on Saturday, May 7 at the Crowne
Plaza London Docklands. This workshop will feature Dr. Florian
Sterzing, an experienced user of the TomoTherapy system at the
University Clinic of Heidelberg, who will present an interactive
session on planning techniques, followed by a hands-on workshop for
attendees.
Then, on May 10, TomoTherapy will host "A Better Way" lunchtime
symposium from 1 p.m. to 2:30 p.m. at the Capital Suites in the ICC
Convention Center. The event will feature presentations from
renowned radiation oncology experts practicing in Europe and
TomoTherapy Chairman and Co-Founder, Thomas "Rock" Mackie,
Ph.D.
"Our partners in Europe are making great strides in improving
cancer care with the TomoTherapy radiation therapy platform, and we
are honored they can join us at ESTRO to share their successes and
practical implementations of our cutting-edge radiation therapy
system," said Fred Robertson, M.D., TomoTherapy's president and
CEO. "We also look forward to demonstrating our latest
advancements, including Remote Planning, in the exhibit hall so
ESTRO attendees can learn more about how TomoTherapy technology can
deliver a multitude of benefits to their patient population and
cancer center operations."
About TomoTherapy Incorporated TomoTherapy
Incorporated develops, markets and sells advanced radiation therapy
solutions that can be used to treat a wide variety of cancers, from
the most common to the most complex. The ring gantry-based
TomoTherapy® platform combines integrated CT imaging with conformal
radiation therapy to deliver sophisticated radiation treatments
with speed and precision while reducing radiation exposure to
surrounding healthy tissue. TomoTherapy's suite of solutions
include its Hi-Art® treatment system, which has been used to
deliver more than three million CT-guided, helical
intensity-modulated radiation therapy (IMRT) treatment fractions;
the TomoHD™ treatment system, designed to enable cancer centers to
treat a broader patient population with a single device; and the
TomoMobile™ relocatable radiation therapy solution, designed to
improve access and availability of state-of-the-art cancer care.
TomoTherapy's stock is traded on the NASDAQ Global Select Market
under the symbol TOMO. To learn more about TomoTherapy, please
visit TomoTherapy.com.
©2011 TomoTherapy Incorporated. All rights reserved.
TomoTherapy, Tomo, TomoDirect, TQA, TomoHelical, TomoDirect,
TomoHD, Hi-Art, and the TomoTherapy logo are among trademarks,
service marks or registered trademarks of TomoTherapy Incorporated
in the United States and other countries.
Investor Contact: Thomas E. Powell Chief Financial
Officer 608.824.2800 Email Contact Media Contacts: Kevin
O'Malley Director, Corporate Communications 608.824.3384 Email
Contact Susan Lehman Rockpoint Public Relations 510.832.6006 Email
Contact
Tom Online (NASDAQ:TOMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tom Online (NASDAQ:TOMO)
Historical Stock Chart
From Sep 2023 to Sep 2024